J Med Genet

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 23 August 2005. doi:10.1136/jmg.2005.033043
Journal of Medical Genetics 2006;43:193-200
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jmg.2005.033043v1
43/3/193    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raymond, F L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raymond, F L

REVIEW

X linked mental retardation: a clinical guide

F L Raymond

Correspondence to:
F Lucy Raymond
Cambridge Institute of Medical Research, Department of Medical Genetics, University of Cambridge, Addenbrooke’s Hospital, Cambridge, CB2 2XY, UK; flr24{at}cam.ac.uk] Mental retardation is more common in males than females in the population, assumed to be due to mutations on the X chromosome. The prevalence of the 24 genes identified to date is low and less common than expansions in FMR1, which cause Fragile X syndrome. Systematic screening of all other X linked genes in X linked families with mental retardation is currently not feasible in a clinical setting. The phenotypes of genes causing syndromic and non-syndromic mental retardation (NLGN3, NLGN4, RPS6KA3(RSK2), OPHN1, ATRX, SLC6A8, ARX, SYN1, AGTR2, MECP2, PQBP1, SMCX, and SLC16A2) are first discussed, as these may be the focus of more targeted mutation analysis. Secondly, the relative prevalence of genes causing only non-syndromic mental retardation (IL1RAPL1, TM4SF2, ZNF41, FTSJ1, DLG3, FACL4, PAK3, ARHGEF6, FMR2, and GDI) is summarised. Thirdly, the problem of recurrence risk where a molecular genetics diagnosis has not been made and what proportion of the male excess of mental retardation is due to monogenic disorders of the X chromosome are discussed.


Keywords: mental retardation; recurrence risks; X chromosome; X linked; X linked mental retardation; XLMR




This article has been cited by other articles:


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
W. Reardon and D. Donnai
Dysmorphology demystified
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2007; 92(3): F225 - F229.
[Full Text] [PDF]


Home page
J. Med. Genet.Home page
H L Archer, J Evans, S Edwards, J Colley, R Newbury-Ecob, F O'Callaghan, M Huyton, M O'Regan, J Tolmie, J Sampson, et al.
CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients
J. Med. Genet., September 1, 2006; 43(9): 729 - 734.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.